Literature DB >> 25149415

Mitochondria: roles in pulmonary hypertension.

Véronique Freund-Michel1, Nafiisha Khoyrattee2, Jean-Pierre Savineau2, Bernard Muller2, Christelle Guibert2.   

Abstract

Mitochondria are essential cell organelles responsible for ATP production in the presence of oxygen. In the pulmonary vasculature, mitochondria contribute to physiological intracellular signalling pathways through production of reactive oxygen species and play the role of oxygen sensors that coordinate hypoxic pulmonary vasoconstriction. Mitochondria also play a pathophysiological role in pulmonary hypertension (PH). This disease is characterized by increased pulmonary arterial pressure and remodelling of pulmonary arteries, leading to increased pulmonary vascular resistance, hypertrophy of the right ventricle, right heart failure and ultimately death. Mitochondrial alterations have been evidenced in PH in pulmonary arteries and in the right ventricle, in particular a chronic shift in energy production from mitochondrial oxidative phosphorylation to glycolysis. This shift, initially described in cancer cells, may play a central role in PH pathogenesis. Further studies of these metabolic mitochondrial alterations in PH may therefore open new therapeutic perspectives in this disease.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mitochondria; Mitochondrial dysfunction; Pulmonary arterial remodelling; Pulmonary hypertension; Right ventricular hypertrophy

Mesh:

Substances:

Year:  2014        PMID: 25149415     DOI: 10.1016/j.biocel.2014.08.012

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  24 in total

Review 1.  Mitochondrial bioenergetics and pulmonary dysfunction: Current progress and future directions.

Authors:  Vadim S Ten; Veniamin Ratner
Journal:  Paediatr Respir Rev       Date:  2019-04-12       Impact factor: 2.726

Review 2.  Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.

Authors:  Kurt R Stenmark; Rubin M Tuder; Karim C El Kasmi
Journal:  J Appl Physiol (1985)       Date:  2015-04-30

3.  The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases.

Authors:  Kiichi Nakahira; Shu Hisata; Augustine M K Choi
Journal:  Antioxid Redox Signal       Date:  2015-08-17       Impact factor: 8.401

Review 4.  Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature.

Authors:  Gerald J Maarman; Rainer Schulz; Karen Sliwa; Ralph Theo Schermuly; Sandrine Lecour
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

5.  Platelets from pulmonary hypertension patients show increased mitochondrial reserve capacity.

Authors:  Quyen L Nguyen; Catherine Corey; Pamela White; Annie Watson; Mark T Gladwin; Marc A Simon; Sruti Shiva
Journal:  JCI Insight       Date:  2017-03-09

Review 6.  Melatonin, mitochondria and hypertension.

Authors:  Ovidiu C Baltatu; Fernanda G Amaral; Luciana A Campos; Jose Cipolla-Neto
Journal:  Cell Mol Life Sci       Date:  2017-08-08       Impact factor: 9.261

Review 7.  Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Jessica H Huston; Sanjiv J Shah
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

8.  Sex differences and altered mitophagy in experimental pulmonary hypertension.

Authors:  Isabel S Bazan; So-Jin Kim; Taylor A Ardito; Yi Zhang; Peiying Shan; Maor Sauler; Patty J Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-02-09       Impact factor: 6.011

9.  Increased Pyruvate Dehydrogenase Kinase 4 Expression in Lung Pericytes Is Associated with Reduced Endothelial-Pericyte Interactions and Small Vessel Loss in Pulmonary Arterial Hypertension.

Authors:  Ke Yuan; Ning-Yi Shao; Jan K Hennigs; Marielle Discipulo; Mark E Orcholski; Elya Shamskhou; Alice Richter; Xinqian Hu; Joseph C Wu; Vinicio A de Jesus Perez
Journal:  Am J Pathol       Date:  2016-07-25       Impact factor: 4.307

10.  Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.

Authors:  Hui Zhang; Daren Wang; Min Li; Lydie Plecitá-Hlavatá; Angelo D'Alessandro; Jan Tauber; Suzette Riddle; Sushil Kumar; Amanda Flockton; B Alexandre McKeon; Maria G Frid; Julie A Reisz; Paola Caruso; Karim C El Kasmi; Petr Ježek; Nicholas W Morrell; Cheng-Jun Hu; Kurt R Stenmark
Journal:  Circulation       Date:  2017-09-26       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.